Study on the Use of Botulinum Toxin Type A in the Treatment of Chronic Post-stroke Spastic Patients "B-CAUSE"

Completed

Phase N/A Results N/A

Main Contacts

Name Phone E-mail
Ipsen Study Director Study Director
Ipsen Recruitment Enquiries Contact clinical.trials@ipsen.com
Aurelio Yamada, MD Study Director